Share
Market Research Report

INDUCED PLURIPOTENT STEM CELLS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Cell SourceSkin derived iPSCs · Blood derived iPSCs · Urine Derived iPSCs · Hepatocytes derived iPSCs · Lung fibroblast derived iPSCs and Others
  • By ApplicationCulture & Maintenance · Differentiation · Genetic Manipulation & Engineering · Characterization & Validation · Banking & Storage and Others
  • By End UserHospitals · Diagnostics Centers · Pharmaceutical & Biotechnology Companies · Contract Research Organizations and Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In27 Mar 2026
  • Report CodeCMI6630
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Induced Pluripotent Stem Cells Market Snippet, By Cell Source
      • Global Induced Pluripotent Stem Cells Market Snippet, By Application
      • Global Induced Pluripotent Stem Cells Market Snippet, By End User
      • Global Induced Pluripotent Stem Cells Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Key Highlights
    • Regulatory Scenario
    • Recent Trends
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Mergers, Acquisitions, and Collaborations
  4. Global Induced Pluripotent Stem Cells Market, By Cell Source, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Skin derived iPSCs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Blood derived iPSCs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Urine Derived iPSCs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Hepatocytes derived iPSCs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Lung fibroblast derived iPSCs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Others (Endothelial cells, Glial Cells, Adipose stem cells etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
  5. Global Induced Pluripotent Stem Cells Market, By Application, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Culture & Maintenance
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Differentiation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Genetic Manipulation & Engineering
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Characterization & Validation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Banking & Storage
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Others (Reprogramming kits, Analysis software etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
  6. Global Induced Pluripotent Stem Cells Market, By End User, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Diagnostics Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Pharmaceutical & Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Contract Research Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Others (Academic & Research Institutes etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
  7. Global Induced Pluripotent Stem Cells Market, By Region, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022 - 2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  8. Competitive Landscape

    • Company Profile
      • Takara Bio Inc.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Thermo Fisher Scientific
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Fujifilm Holdings Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Astellas Pharma
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Fate Therapeutics
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Ncardia
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • ViaCyte
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Cellular Dynamics International
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Lonza
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Blueprint Medicines
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Other Prominent Players
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
    • Analyst Views
  9. Section

    • References
    • Research Methodology
    • About us